Evidence map›Paper›PMID 24497833›Full record

ArticlePLoS pathogens2014

Plasmacytoid dendritic cell dynamics tune interferon-alfa production in SIV-infected cynomolgus macaques.

Timothée Bruel, Stéphanie Dupuy, Thomas Démoulins, Christine Rogez-Kreuz, Jacques Dutrieux, Aurélien Corneau, Antonio Cosma, Rémi Cheynier, Nathalie Dereuddre-Bosquet, Roger Le Grand and 1 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 51 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Infection and cancer suppress pDC derived IFN-I.Current opinion in immunology · 2020
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Timothée BruelDivision of Immuno-Virology, Institute of Emerging Diseases and Innovative Therapies, CEA, Fontenay-aux-Roses, France ; Unité Mixte de Recherche UMR-E01, Université Paris-Sud, Orsay, France.
Stéphanie DupuyDivision of Immuno-Virology, Institute of Emerging Diseases and Innovative Therapies, CEA, Fontenay-aux-Roses, France ; Unité Mixte de Recherche UMR-E01, Université Paris-Sud, Orsay, France.
Thomas DémoulinsDivision of Immuno-Virology, Institute of Emerging Diseases and Innovative Therapies, CEA, Fontenay-aux-Roses, France ; Unité Mixte de Recherche UMR-E01, Université Paris-Sud, Orsay, France.
Christine Rogez-KreuzNeurovirology Laboratory, Bertin Pharma, Fontenay-aux-Roses, France.
Jacques DutrieuxUniversité Paris Descartes, Sorbonne Paris Cité, Paris, France ; INSERM, U1016, Institut Cochin, Paris, France ; CNRS, UMR8104, Paris, France ; Université Paris Diderot, Paris, France.
Aurélien CorneauDivision of Immuno-Virology, Institute of Emerging Diseases and Innovative Therapies, CEA, Fontenay-aux-Roses, France.
Antonio CosmaDivision of Immuno-Virology, Institute of Emerging Diseases and Innovative Therapies, CEA, Fontenay-aux-Roses, France ; Unité Mixte de Recherche UMR-E01, Université Paris-Sud, Orsay, France.
Rémi CheynierINSERM, U1016, Institut Cochin, Paris, France ; CNRS, UMR8104, Paris, France ; Université Paris Diderot, Paris, France.
Nathalie Dereuddre-BosquetDivision of Immuno-Virology, Institute of Emerging Diseases and Innovative Therapies, CEA, Fontenay-aux-Roses, France ; Unité Mixte de Recherche UMR-E01, Université Paris-Sud, Orsay, France.
Roger Le GrandDivision of Immuno-Virology, Institute of Emerging Diseases and Innovative Therapies, CEA, Fontenay-aux-Roses, France ; Unité Mixte de Recherche UMR-E01, Université Paris-Sud, Orsay, France.
Bruno VaslinDivision of Immuno-Virology, Institute of Emerging Diseases and Innovative Therapies, CEA, Fontenay-aux-Roses, France ; Unité Mixte de Recherche UMR-E01, Université Paris-Sud, Orsay, France.
Infectious Disease Models and Innovative Therapies · FRUniversité Paris-Sud · FRCEA Paris-Saclay - Etablissement de Fontenay-aux-roses · FRDélégation Paris 5 · FRDélégation Paris 7 · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

IFN-I production is a characteristic of HIV/SIV primary infections. However, acute IFN-I plasma concentrations rapidly decline thereafter. Plasmacytoid dendritic cells (pDC) are key players in this production but primary infection is associated with decreased responsiveness of pDC to TLR 7 and 9 triggering. IFNα production during primary SIV infection contrasts with increased pDC death, renewal and dysfunction. We investigated the contribution of pDC dynamics to both acute IFNα production and the rapid return of IFNα concentrations to pre-infection levels during acute-to-chronic transition. Nine cynomolgus macaques were infected with SIVmac251 and IFNα-producing cells were quantified and characterized. The plasma IFN-I peak was temporally associated with the presence of IFNα(+) pDC in tissues but IFN-I production was not detectable during the acute-to-chronic transition despite persistent immune activation. No IFNα(+) cells other than pDC were detected by intracellular staining. Blood-pDC and peripheral lymph node-pDC both lost IFNα(-) production ability in parallel. In blood, this phenomenon correlated with an increase in the counts of Ki67(+)-pDC precursors with no IFNα production ability. In tissues, it was associated with increase of both activated pDC and KI67(+)-pDC precursors, none of these being IFNα(+) in vivo. Our findings also indicate that activation/death-driven pDC renewal rapidly blunts acute IFNα production in vivo: pDC sub-populations with no IFNα-production ability rapidly increase and shrinkage of IFNα production thus involves both early pDC exhaustion, and increase of pDC precursors.

Indexed as

AnimalsDendritic CellsInterferon-alphaLymph NodesMacaca fascicularisPlasma CellsSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusToll-Like Receptor 7Toll-Like Receptor 9Interferon-alphaToll-Like Receptor 7Toll-Like Receptor 9

Identifiers

PMID24497833
PMCPMC3907389
OpenAlexW2035500532

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.